(Kaiser Health News, 2-16-17)
The latest flashpoint in the ongoing debate over high drug prices is Emflaza, an $89,000-a-year drug that treats Duchenne muscular dystrophy.
(The New York Times, 2-15-17)
The cost of medical care in the United States is expected to grow at a faster clip over the next decade and overall health spending growth will outpace that of the gross domestic product, a U.S. government health agency said on Wednesday.
(The Washington Post, 2-15-17)
U.S. health-care spending grew 4.8 percent last year, as the country has emerged from a period of historically low health spending growth, according to new federal estimates.
(Modern Healthcare, 2-11-17)
The just-departed commissioner of the Food and Drug Administration has concerns about plans to speed up drug approvals and dramatically reduce regulations at the agency, as advocated recently by President Donald Trump.
(Bloomberg BNA, 2-10-17)
Sicker-than-expected Obamacare enrollees caused many insurers to lose money and leave the exchanges, increasing premiums for remaining enrollees.
(Business Insider, 2-9-17)
Out-of-pocket healthcare costs in the US areamong the fastest-growing expensesfor Americans, and they can be devastating.
In 1971, the Food and Drug Administration approved the first drug that could reverse a heroin or opioid overdose. More than 40 years later, makers of this drug, callednaloxone, are cashing in on the nation’sopioid painkiller and heroin epidemicand price-gouging consumers.
When you have your health, your health-care costs in retirement will be high. And when you do not have your health, those costs will be even higher.
Uninsured rates in low-income families have fallen under the Affordable Care Act, yet more than a third of Americans continued to face difficulties paying their medical bills in 2016, a survey found.
(Washington Post, 1-27-17)
American health-care spending, measured in trillions of dollars, boggles the mind. Last year, we spent $3.2 trillion on health care — a number so large that it can be difficult to grasp its scale.
(The Hill, 1-26-17)
Everyone talks about how healthcare costs are rising. But there are ways for you to control your healthcare costs. Here are eight such ways.
(The Wall Street Journal, 1-25-17)
With Congress now reconsidering rules affecting the U.S. health-insurance system, it’s worth taking a look at what lawmakers are up against: an expensive health-care network that doesn’t deliver the best results to the most people at the lowest cost.
(The New York Times, 1-23-17)
American life spans are rising, and as they are, health care spending is, too. But longevity is not contributing to the spending increase as much as you might think.
(Business Insider, 1-23-17)
It’s shaping up to be another rough year for the drug industry.
(Kaiser Health News, 12-20-16)
As drug prices have spiraled upward in the past decade, tens of millions of generally law-abiding Americans have committed an illegal act in response: They have bought prescriptions outside the U.S. and imported them.
(The Hill, 12-19-16)
Doctors commonly prescribe drugs to treat conditions the medications weren’t designed for, but for drugmakers, discussing such “off-label” uses can lead to trouble.
(Harvard Business Review, 12-12-16)
The starting point for achieving value in any health care system is to measure outcomes.
(Yahoo News, 12-04-16)
The pace of U.S. health care spending picked up slightly last year, reaching a total of $3.2 trillion or $9,990 per person in the country. While a number of factors were at play, the increase was largely due to expanded coverage of individuals who signed up for Obamacare or who took advantage of a major expansion of Medicaid, according to a new study released on Friday.